Use of Eltrombopag in Children With Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

Background: The thrombopoietin receptor agonist eltrombopag has been shown to be safe and effective for children with chronic immune thrombocytopenia (ITP). The aim of the present study was to characterize eltrombopag use in current clinical practice. Material and Methods: This is a retrospective mu...

Full description

Saved in:
Bibliographic Details
Published in:Front Med (Lausanne)
Main Authors: Giordano, Paola, Lassandro, Giuseppe, Barone, Angelica, Cesaro, Simone, Fotzi, Ilaria, Giona, Fiorina, Ladogana, Saverio, Miano, Maurizio, Marzollo, Antonio, Nardi, Margherita, Notarangelo, Lucia Dora, Pession, Andrea, Ruggiero, Antonio, Russo, Giovanna, Saracco, Paola, Spinelli, Marco, Tolva, Alessandra, Tornesello, Assunta, Palladino, Valentina, Del Vecchio, Giovanni Carlo
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Medicine
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059456/
https://ncbi.nlm.nih.gov/pubmed/32181255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.00066
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items